7-Ethylcamptothecin

CAS No. 78287-27-1

7-Ethylcamptothecin( —— )

Catalog No. M19104 CAS No. 78287-27-1

7-Ethylcamptothecin remains in the intestinal tract for a longer time and in higher amounts when administered in vivo.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
100MG Get Quote In Stock
200MG 33 In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    7-Ethylcamptothecin
  • Note
    Research use only, not for human use.
  • Brief Description
    7-Ethylcamptothecin remains in the intestinal tract for a longer time and in higher amounts when administered in vivo.
  • Description
    7-Ethylcamptothecin has the superior antitumor activity than CPT. 7-Ethylcamptothecin has a stronger growth-inhibiting activity against tumor cells. 7-Ethylcamptothecin remains in the intestinal tract for a longer time and in higher amounts when administered in vivo.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Apoptosis
  • Target
    PKA
  • Recptor
    Others
  • Research Area
    Cancer
  • Indication
    ——

Chemical Information

  • CAS Number
    78287-27-1
  • Formula Weight
    376.41
  • Molecular Formula
    C22H20N2O4
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 5 mg/mL (13.28 mM助)
  • SMILES
    CCC1=C2CN3C(=CC4=C(C3=O)COC(=O)C4(CC)O)C2=NC5=CC=CC=C51
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • JAK1/2/3 Inhibitor 1

    JAK1/2/3 Inhibitor 1 is a potent protein kinase inhibitor.JAK1/2/3 Inhibitor 1 has antitumor activity that inhibits the growth of a variety of cancer cell lines.

  • 8-Bromo-cGMP sodium

    8-Bromo-cGMP sodium is a PKG activator, a membrane-permeable analog of cGMP.

  • Rp-cAMPS sodium

    Rp-cAMPS sodium is a phosphorothioate analog of cAMP, a protein kinase A inhibitor and a membrane-permeable cAMP antagonist that inhibits cAMP-dependent protein kinases by blocking cAMP-induced conformational transitions, and can be used in the study of cardiovascular diseases.